• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

基于生物信息学筛选乳腺癌放疗抵抗相关微小RNA的研究

Screening of microRNAs involved in radiation resistance of breast cancer based on bioinformatics

摘要目的 筛选乳腺癌放射治疗(放疗)抵抗相关微小RNA(miRNAs),为乳腺癌患者放疗抵抗的基础研究与临床应用研究提供实验基础.方法 从基因表达综合数据库(GEO)中下载乳腺癌放疗患者相关miRNAs微阵列数据集GSE 107743,利用GEO2R分析工具筛选放疗后局部复发患者的差异表达miRNAs,mirDIP数据库预测差异表达miRNAs的靶基因,DAVID数据库对靶基因分别进行基因本体论(GO)富集分析和京都基因与基因组百科全书(KEGG)通路富集分析.最后采用实时荧光定量PCR在人乳腺癌细胞MCF-7中进行差异表达验证.结果 采用GEO2R分析工具筛选出9种与放疗抵抗相关的差异表达miRNAs,其中3种miRNAs(hsa-miR-600、hsa-miR-525-3p、hsa-miR-591)表达上调,6种miRNAs(hsa-miR-488-5p、hsa-miR-582-3p、hsa-miR-520h、hsa-miR-488-3p、hsa-miR-744-3p、hsa-miR-103b)表达下调.靶基因预测结果显示,9种差异表达miRNAs的潜在靶基因共134个.靶基因显著富集在细胞周期、细胞凋亡、干细胞分化等相关生物学过程(均P<0.05)以及转化生长因子-β、磷脂酰肌醇3-激酶\蛋白激酶B信号通路等信号通路中(均P<0.05).实时荧光定量PCR检测结果表明,6种miRNAs (hsa-miR-600、hsa-miR-525-3p、hsa-miR-591、hsa-miR488-5p、hsa-miR-582-3p、hsa-miR-520h)在经5 Gy 137Csγ射线辐照后的MCF-7细胞中表达差异改变与GEO2R分析结果完全一致.结论 利用生物信息学从乳腺癌放疗患者局部复发临床样本中筛选出的差异表达miRNAs可能与乳腺癌患者的放疗抵抗密切相关,有望成为放疗抵抗治疗的新靶点.

更多

abstractsObjective To screen radiotherapy resistance related microRNAs (miRNAs) in breast cancer and provide experimental basis for basic researches and clinical solutions of radiotherapy resistance in breast cancer patients.Methods The miRNA microarray dataset GSE107743 related to breast cancer radiotherapy patients was downloaded from the Gene Expression Omnibus (GEO).The GEO2R analysis tool was used to screen differentially expressed miRNAs in patients with local recurrence after radiotherapy.The target genes of differentially expressed miRNAs were predicted by the mirDIP database.GO enrichment analysis and KEGG pathway analysis on the target genes were performed by DAVID dataset.Finally,differential expression verification was performed in human breast cancer cell line MCF-7 by real-time fluorescent quantitative PCR.Results A total of 9 differentially expressed miRNAs related to radiotherapy resistance were screened by the GEO2R analysis tool,in which three miRNAs (hsa-miR-600,hsa-miR-525-3p and hsa-miR-591) were up-regulated and 6 miRNAs (hsa-miR-488-5p,hsa-miR-582-3p,hsa-miR-520h,hsa-miR-488-3p,hsa-miR-744-3p and hsa-miR-103b) were down-regulated.Target gene prediction results showed that there were 134 potential target genes in these nine differentially expressed miRNAs.These target genes were significantly enriched in related biological processes such as apoptosis and stem cell differentiation (all P<0.05) and signal transduction pathways such as transforming growth factor-β and phosphatidylinositol 3-kinase-protein kinase B signaling pathway (all P<0.05).The results of real-time PCR showed that the differential expression of six miRNAs,i.e.hsa-miR-600,hsa-miR-525-3p,hsa-miR-591,hsa-miR488-5p,hsa-miR-582-3p and hsa-miR-520h,was detected in the MCF-7 cells irradiated by 5 Gy 137Cs γ-rays,and this result was consistent with the results of GEO2R analysis.Conclusion The differentially expressed miRNAs screened from clinical samples of breast cancer patients with local recurrence using bioinformatics may be closely associated with the radiotherapy resistance of these patients.These miRNAs are expected to become new biomarkers for the therapy of radiotherapy resistance.

More
广告
栏目名称 论著
DOI 10.3760/cma.j.issn.1673-4181.2018.03.009
发布时间 2018-08-27
基金项目
国家自然科学基金 科技部科研院所技术开发研究专项项目 天津市科技支撑项目 中国医学科学院医学与健康技术创新工程(2016-I2M-1-017)National Natural Science Foundation of China Key Technology Research and Development Program of Tianjin Special Research Funds for Technical Development of Research Institutes from the Ministry of Science and Technology of China CAMS Innovation Fund for Medical Sciences
  • 浏览87
  • 下载88
国际生物医学工程杂志

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷